Yi Larson - Dec 1, 2021 Form 4 Insider Report for LianBio (LIAN)

Role
Chief Financial Officer
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
4
Date filed
12/3/2021, 03:05 PM
Previous filing
Nov 1, 2021
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Award $0 +6K +0.5% $0.00 1.2M Dec 1, 2021 Ordinary Shares 6K $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest and become exercisable on December 1, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on December 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.